NCT02783040View on ClinicalTrials.gov

Interaction of BI 425809 With Midazolam, Warfarin, Omeprazole and Digoxin

PHASE1CompletedINTERVENTIONAL
Enrollment

13

Participants

Timeline

Start Date

September 30, 2015

Primary Completion Date

October 31, 2015

Study Completion Date

October 31, 2015

Conditions
Healthy
Interventions
DRUG

Midazolam

DRUG

Warfarin

DRUG

Omeprazole

DRUG

Midazolam

DRUG

Digoxin

DRUG

BI 425809

Trial Locations (1)

Unknown

1346.22.1 Boehringer Ingelheim Investigational Site, Biberach

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY